Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

Similar articles for PubMed (Select 23389310)

1.

[The SHARP study].

Bianchi S, Gaspardone A.

G Ital Cardiol (Rome). 2013 Feb;14(2):87-91. doi: 10.1714/1218.13520. Italian. No abstract available.

PMID:
23389310
2.

In brief: Ezetimibe/simvastatin (Vytorin) in chronic kidney disease.

[No authors listed]

Med Lett Drugs Ther. 2012 Jan 9;54(1381):4. No abstract available.

PMID:
22233589
3.

Efficacy of simvastatin and ezetimibe in treating hypercholesterolemia.

Davidson MH.

J Am Coll Cardiol. 2003 Jul 16;42(2):398-9; author reply 399. No abstract available.

4.

[Target values are more often attainable. Almost doubly so many patients with values under 100mg/dl].

[No authors listed]

MMW Fortschr Med. 2004 Oct 28;146(44):57. German. No abstract available.

PMID:
15566254
5.

Ezetimibe + simvastatin (Merck/Schering-Plough).

Flores NA.

Curr Opin Investig Drugs. 2004 Sep;5(9):984-92. Review.

PMID:
15503655
6.

[Dual cholesterol inhibition. More high risk patients achieve LDL cholesterol values below 100 mg/dl].

[No authors listed]

MMW Fortschr Med. 2008 Jun 5;150(23):39. German. No abstract available.

PMID:
18575369
7.

[Combination of Zocor with Ezetrol].

Thibaut P, Sternon J.

Rev Med Brux. 2006 Nov-Dec;27(6):S526. French. No abstract available.

PMID:
17256422
8.

Is ezetimibe/simvastatin no better than simvastatin alone? Lessons learned and clinical implications.

Davidson MH.

Cleve Clin J Med. 2008 Jul;75(7):479-82, 486-8, 490-1. No abstract available.

PMID:
18646584
9.

After ENHANCE: the cholesterol hypothesis is alive and well.

Hamilton-Craig IR.

Med J Aust. 2008 Sep 15;189(6):303-4. No abstract available.

PMID:
18803531
10.

The ENHANCE trial.

Porat G.

Cleve Clin J Med. 2008 Nov;75(11):763, 767; author reply 767. No abstract available.

PMID:
19086111
11.

The ENHANCE trial.

Fee WH Jr.

Cleve Clin J Med. 2008 Nov;75(11):763; author reply 767. No abstract available.

PMID:
19068956
12.

Premature release of data from clinical trials of ezetimibe.

Califf RM, Harrington RA, Blazing MA.

N Engl J Med. 2009 Aug 13;361(7):712-7. doi: 10.1056/NEJMsr0900910. No abstract available.

13.

Ezetimibe revisited.

[No authors listed]

Med Lett Drugs Ther. 2008 Aug 25;50(1293):67-8. No abstract available.

PMID:
18719525
14.

After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.

Mascitelli L, Ravnskov U, Pezzetta F, Goldstein MR.

Angiology. 2009 Feb-Mar;60(1):127-8; author reply 129-30. doi: 10.1177/0003319708327788. Epub 2008 Dec 1. No abstract available.

PMID:
19049996
15.

Ezetimibe and recent clinical trials: a look on the bright side.

Ahmed MH.

Expert Opin Drug Saf. 2010 Jul;9(4):511-4. doi: 10.1517/14740331003702376.

PMID:
20377476
16.
17.

Simvastatin + ezetimibe: a combination with no proven advantages.

[No authors listed]

Prescrire Int. 2007 Apr;16(88):67. No abstract available.

PMID:
17460829
18.

ENHANCE: food for the ostriches.

Jackson G.

Int J Clin Pract. 2008 May;62(5):667-8. doi: 10.1111/j.1742-1241.2008.01740.x. No abstract available.

PMID:
18412925
19.

[New combination therapy. Up to 60% lower LDL cholesterol level].

[No authors listed]

MMW Fortschr Med. 2004 May 6;146(19):63. German. No abstract available.

PMID:
15357489
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk